List of works - Ivana Sestak

Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial

scientific article published on 14 September 2009

CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

scientific article published on 6 March 2012

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

scientific article

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer ⬇️

scientific article

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

scientific article published on 17 November 2010

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

scientific article published on 14 June 2010

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

scientific article

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

scientific article

Factors predicting late recurrence for estrogen receptor-positive breast cancer

scientific article published on 12 September 2013

Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study.

scientific article published on 13 July 2013

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials

scientific article published on 28 December 2016

Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial

article

Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms

scientific article published in August 2006

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

scientific article

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

scientific article published on 30 April 2019

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

scientific article published on 12 September 2013

Preventive therapy for breast cancer.

scientific article

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.

scientific article published on 11 July 2016

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial.

scientific article

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.

scientific article published on 22 July 2016

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

scientific article published on 12 August 2008

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

scientific article

The effect of behavioural risk factors on osteoporosis in Irish women.

scientific article published on 28 July 2012

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

scientific article

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

scientific article published on 12 December 2019

Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer

scientific article published on 16 May 2012

List of works by Ivana Sestak

Aromatase inhibitor-induced carpal tunnel syndrome: results from the ATAC trial

CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients

Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy.

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer ⬇️

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

Factors predicting late recurrence for estrogen receptor-positive breast cancer

Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study.

Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials

Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial

Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone

Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.

Preventive therapy for breast cancer.

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials.

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial.

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

The effect of behavioural risk factors on osteoporosis in Irish women.

Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer